Cargando…
Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study
The Comprehensive Economic and Trade Agreement between Canada and the European Union provides for an extension of Canadian patents for prescription drugs by up to 2 years. One of the arguments advanced for longer patent time is to compensate companies for the length of the overall drug development t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Kerman University of Medical Sciences
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056197/ https://www.ncbi.nlm.nih.gov/pubmed/32610816 http://dx.doi.org/10.34172/ijhpm.2020.100 |